CCC | J535 |
CAS | 70-51-9 |
Wiki | Deferoxamine |
Deferoxamine is a bacterial siderophore produced by the actinobacter Streptomyces pilosus. It has medical applications as a chelating agent used to remove excess iron from the body. The mesylate salt of DFO-B is commercially available.Deferoxamine is used to treat acute iron poisoning, especially in small children. This agent is also frequently used to treat hemochromatosis, a disease of iron accumulation that can be either genetic or acquired.
Deferoxamine acts by binding free iron in the bloodstream and enhancing its elimination in the urine. By removing excess iron, the agent reduces the damage done to various organs and tissues, such as the liver. A recent study also shows that it speeds healing of nerve damage (and minimizes the extent of recent nerve trauma). Deferoxamine may modulate expression and release of inflammatory mediators by specific cell types.
Organism species: Pan-species (General)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Complete Antigen of Deferrioxamine (DFOM) | Antigenic Transformation Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Deferrioxamine (DFOM) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Deferrioxamine (DFOM) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Deferrioxamine (DFOM) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Deferrioxamine (DFOM) | ELISA Kit Customized Service Offer |